Fluvoxamine EP Impurity B is an impurity that can occur in Fluvoxamine formulations due to specific synthesis or storage conditions.

Regulatory bodies require monitoring impurities like Fluvoxamine EP Impurity B to ensure the safety and efficacy of Fluvoxamine formulations.

It forms as a by-product under specific conditions such as temperature or pH variations during synthesis or storage.

Proper storage conditions and regular quality checks help minimize the formation of this impurity.

GC-MS, LC-MS, and HPLC-MS are commonly used methods for accurate detection and profiling of Fluvoxamine EP Impurity B.

Chemicea provides COA, H-NMR, MASS, HPLC, and TGA reports as standard, with additional reports like CNMR, IR, UV, DEPT, Water content, and CHNS available upon request.

Yes, Chemicea’s documentation meets the standards required by major regulatory agencies such as USFDA, EMA, ANVISA, TGA, and PMDA.

It is stable for shipping at room temperature, with specific storage guidelines provided in the COA.

Yes, Chemicea offers both standard and customized pack sizes to meet specific client requirements.

Chemicea supplies Fluvoxamine EP Impurity B as a reference standard, supporting regulatory compliance, method validation, and impurity profiling in Fluvoxamine formulations.